PARICALCITOL | HOSPIRA | ||
0.002MG/ML (0.002MG/ML),0.005MG/ML (0.005MG/ML),0.01MG/2ML (0.005MG/ML) | |||
No | Yes | ||
Expired | Expired | ||
None | None | ||
None | No | ||
Paricalcitol Injection is a vitamin D2 analog indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease on dialysis |
0 | 0 | 0 |
Total Other Developers | 1 |
---|
Drugs with Suitability | No |
---|
0.002MG/ML (0.002MG/ML) | ** | ** | - | - | - |
0.005MG/ML (0.005MG/ML) | ** | ** | - | - | - |
0.01MG/2ML (0.005MG/ML) | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com